DAX6.050-3,4%  Dow12.119-2,2%  Euro1,24320,6% 
ESt502.069-2,4%  Nas2.748-2,8%  Öl98,82-2,8% 
TDax730,9-2,7%  Nikkei8.440-1,2%  Gold1.6264,2% 
Home > Aktien > Neurogen Aktie > Nachrichten zu Neurogen

Neurogen Aktie [WKN: 881778 / ISIN: US64124E1064]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
BörsenplätzeChartvergleichKursziele InsidertradesKnock-outsmyHome
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
HistorischRealtime PushmyNews neu IR-DatenAnleihen
handeln
Diese Aktie wird nicht mehr gehandelt

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur Neurogen Corp.. Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur Neurogen Corp.

17.12.09Neurogen Corporation Receives Notice from NASDAQ Regarding Listing of Securities
06.11.09Neurogen Corporation Announces Third Quarter 2009 Financial Results and Updates Operations
04.11.09Neurogen Corporation Announces Webcast of Third Quarter 2009 Financial Results on November 6
14.08.09Neurogen Corporation Announces Second Quarter 2009 Financial Results
07.08.09Neurogen Corporation Announces Webcast of Second Quarter 2009 Financial Results on August 14, 2009
12.05.09Neurogen Corporation Announces First Quarter 2009 Financial Results and Updates Strategic and Operating Plans
08.05.09Neurogen Corporation Announces Webcast of First Quarter 2009 Financial Results on May 12, 2009
08.04.09Neurogen Corporation’s Auditors Expressed Going Concern Qualification
19.03.09Neurogen Corporation Announces 2008 Financial Results
10.03.09Neurogen Corporation Announces Webcast of Fourth Quarter 2008 Financial Results on March 19, 2009
23.12.08Neurogen Corporation Announces Agreement for Sale of Its C5a Patent Estate and Related Assets for $2.25 Million and Receipt of Final Payment on $3 Million Sale of Chemical Library
02.12.08Neurogen Corporation Announces Termination of Facilities Sale Agreement
14.11.08Neurogen Corporation Announces Agreements for Sale of Non-Core Assets for Combined $9 Million
07.11.08Neurogen Corporation Announces Third Quarter 2008 Financial Results and Updates Operations
04.11.08Neurogen Corporation Announces Webcast of Third Quarter 2008 Financial Results on November 7, 2008
23.10.08Neurogen Corporation Receives Extension from NASDAQ
14.10.08Neurogen Announces Positive Results for Aplindore in Restless Legs Syndrome and Parkinson's Disease
27.08.08Neurogen Corporation Receives Notification from Nasdaq
07.08.08Neurogen Corporation Announces Second Quarter 2008 Financial Results
01.08.08Neurogen Corporation Announces Webcast of Second Quarter 2008 Financial Results on August 7, 2008
13.07.08Neurogen Announces Suspension of Insomnia Study with Adipiplon
08.05.08Neurogen Corporation Announces First Quarter 2008 Financial Results
05.05.08Neurogen Corporation Announces Webcast of First Quarter 2008 Financial Results on May 8, 2008
24.04.08Neurogen Corporation Announces Executive Appointments
09.04.08Neurogen Announces $30.6 Million Financing to Advance Clinical Development Programs
23.03.08Neurogen Corporation's Auditors Expressed Going Concern Qualification
17.03.08Neurogen Corporation Announces 2007 Financial Results
11.03.08Neurogen Corporation Announces Webcast of Fiscal 2007 Financial Results on March 17
15.02.08Neurogen Announces Appointment of Dr. John L. LaMattina to Board of Directors
08.02.08Neurogen Announces R&D Update
06.02.08CORRECTING and REPLACING Neurogen Restructures to Focus Resources on Advancing Clinical Programs
06.02.08Neurogen Restructures to Focus Resources on Advancing Clinical Programs
04.02.08Neurogen Corporation Announces Appointment of Stephen R. Davis as President & CEO
08.01.08Neurogen Announces Results of Multiple Ascending Dose Studies with Experimental Obesity Drug
08.11.07Neurogen Corporation Announces Third Quarter 2007 Financial Results
07.11.07Neurogen Corporation Announces Webcast of November 14 Presentation at Credit Suisse Healthcare Conference
06.11.07Neurogen Announces Adipiplon Preclinical and Clinical Data to Be Presented at Neuroscience 2007
06.11.07Neurogen Announces Aplindore Preclinical Data to Be Presented at Neuroscience 2007
29.10.07Neurogen Corporation Webcast of Third Quarter 2007 Financial Results--Change
25.10.07Neurogen Corporation Announces Webcast of Third Quarter 2007 Financial Results on November 1

Anzeige

ANZEIGE

Seite: 12
Wie bewerten Sie diese Seite?
schlecht sehr gut
Problem mit dieser Seite?
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon